In parallel testing, brain cells will be made from each patient's stem cells to see if they can predict which patients might respond to the medicine. The trial will evaluate the potential of the drug, Retigabine, which has a unique mechanism of action and can calm the excitability of nerve cells that are thought to cause seizures.
http://ift.tt/1PTF9rZ
http://ift.tt/1PTF9rZ
No comments:
Post a Comment